CPB Faculty Member Pursues New Research on Antibiotic-resistant Infections

Dr. Mohamed Seleem, professor of microbiology in PVM’s Department of Comparative Pathobiology, is studying whether FDA-approved drugs can treat antibiotic-resistant infections. (Purdue University photo/Rebecca Wilcox)

With antimicrobial resistance on the rise, many infections once easily treated are becoming fatal. Vancomycin-resistant enterococci (VRE) is to blame for more than 5% of all deaths attributed to antibiotic-resistant infection in the U.S., second only to MRSA. Led by Dr. Mohamed Seleem, professor of microbiology in Purdue Veterinary Medicine’s Department of Comparative Pathobiology, researchers now are exploring whether they could repurpose some drugs, which have already been approved by the FDA, to treat the infection.

Enterococci are bacteria that live in everyone’s intestines and genital tracts. They’re usually harmless, but sometimes they can cause infection, in which case they’re treated with an antibiotic called vancomycin. However, enterococci are becoming resistant to the drug at an alarming rate. This is especially true in hospitals, where VRE is most often acquired. About 20,000 people in the U.S. are infected with VRE each year, and slightly less than 10% of those infections are fatal.

“When vancomycin doesn’t work, you have to give the patient another antibiotic that kills other bacteria you don’t want to kill,” Dr. Seleem said. “So having a drug that would selectively remove the VRE and nothing else would be a great discovery. And it looks like we’ve found several drugs that could work.”

In collaboration with Dr. Daniel Flaherty, assistant professor of medicinal chemistry and molecular pharmacology at Purdue, Dr. Seleem will screen several drugs often used to treat glaucoma, called carbonic anhydrase inhibitors (CAIs), to see how well they can treat VRE.  In previous studies in vitro, CAIs were shown to be more effective at killing VRE than the drugs typically used to treat it. They were also able to sidestep surrounding microorganisms, which is extremely rare, said Dr. Seleem, who researches antimicrobial resistance and infectious disease.  “In the field of microbiology, I have not seen a drug or molecule that specifically kills one kind of microorganism and doesn’t kill anything else,” he said. 

With funding provided by the National Institutes of Health, Dr. Seleem will test six pre-approved drugs against VRE. The bacteria can spread to several different systems within the body and cause other infections, such as urinary tract and blood infections. To make sure the drugs work in all of these cases, several different models will be used in the study.

In previous studies, it took 10 to 15 days for the drugs to kill VRE. The researchers are going to try to speed up that process by making the drugs more potent and finding a way to keep them inside the intestine. Once CAIs reach the intestine, they’re easily absorbed into the rest of the body. But for them to be effective in killing VRE, they need to stay inside the intestine, where they have prolonged exposure to the bacteria.

Dr. Flaherty will create several slightly different versions of the six original drugs and the best of them will move forward to animal studies. The final product could be a drug given on its own or something to work with current VRE drugs to make them more effective. In prior studies, CAIs made enterococci more sensitive to other drugs, increasing their efficiency.

The last task of the project is to figure out how CAIs kill the bacteria. Although the researchers have observed this phenomenon experimentally, they don’t yet understand how it works.

The research aligns with Purdue’s Giant Leaps celebration, acknowledging the University’s global advancements made in health, longevity, and quality of life as part of Purdue’s 150th Anniversary. This is one of the four themes of the yearlong celebration’s Ideas Festival, designed to showcase Purdue as an intellectual center solving real-world issues.

Writer(s): Kayla Zacharias, Purdue News Service | pvmnews@purdue.edu

Recent Stories

Keeping Your Pets Safe from Highly Pathogenic Avian Influenza (HPAI)

The Purdue Veterinary Hospital has not detected Highly Pathogenic Avian Influenza (HPAI) in its practices but is providing important information to help pet and livestock owners stay informed. HPAI affects various species, including birds, cats, dogs, and livestock, and can spread through contact with infected animals or raw food. To reduce risk, avoid feeding raw meat or unpasteurized dairy to pets, limit wildlife exposure, and use protective gear when handling animals. Owners of feline and avian patients will be asked screening questions during appointments.

Purdue Engineering Hosts PVM Canine Educators for ‘Canines, Cookies, and Calm’ During Mental Health Action Week

Purdue Veterinary Medicine’s beloved Canine Educators found themselves amidst a throng of engineering students last Friday, March 7, in the Herman & Heddy Kurz Atrum of Armstrong Hall, where they were the center of attention during an event on the final day of Purdue’s Mental Health Action Week (MHAW). Named “Canines, Cookies, and Calm,” the event hosted by the College of Engineering fostered smiles, laughter, and endless thanks from a total of some 300 engineering students.

“Paws Up” – brought to you by the PVM Wellness Committee

March is National Social Work Month! It’s a perfect time to recognize our very own Veterinary Hospital Social Worker, Jennifer Dehn, LSW, MSW.

In Memory – Dr. Raymond Backe (PU DVM ’66)

The Purdue Veterinary Medicine community mourns the passing of Dr. Ray Backe, an alumnus who was a member of the college’s fourth graduating class – the Class of 1966. Dr. Backe, of Amherst Junction, Wisconsin, formerly of Greendale, Wisconsin, passed away January 19, 2025. He was 84.

Purdue Veterinary Alumni Meet up in Las Vegas at WVC Annual Conference

Purdue University College of Veterinary Medicine alumni stood out from the large crowds of veterinary professionals attending the Viticus Group 2025 WVC Annual Conference in Las Vegas, Nevada as they gathered for the Purdue Veterinary Alumni Reception held in conjunction with the conference. The event Monday evening, March 3, attracted close to 70 alumni who met up at the Rhythm and Rifts lounge located just off the Mandalay Bay casino floor.

Purdue Veterinary Student and Small Animal Surgery Resident Achieve Recognition at Major Specialty Conference

A Purdue second-year veterinary student and a third-year small animal surgery resident helped put the Purdue University College of Veterinary Medicine in the spotlight at the 52nd Annual Conference of the Veterinary Orthopedic Society (VOS) this year.

PVM Associate Dean for Academic Affairs Announces Plans to Retire

An esteemed and dedicated Purdue University College of Veterinary Medicine faculty member and administrator, Dr. S. Kathleen Salisbury, has announced that she will conclude her Purdue career of more than 40 years when she retires effective June 30, 2025. Her decision was shared with the college’s faculty, staff and students by Dean Bret Marsh, DVM, Wednesday (3/12).